Carbohydrate tolerance and insulin responses in obstructive jaundice

Area of Science:

• Endocrinology
• Gastroenterology
• Oncology

Background:

• Obstructive jaundice can impact glucose metabolism and pancreatic endocrine function.
• Differentiating pancreatic cancer from other causes of obstructive jaundice is clinically important.

Purpose of the Study:

• To investigate glucose tolerance and insulin response in patients with obstructive jaundice, specifically comparing those with pancreatic cancer to other causes.
• To assess the utility of glucose tolerance tests (G.T.T.) and insulin stimulation tests in distinguishing pancreatic cancer in obstructive jaundice.

Main Methods:

• Twenty-three patients with obstructive jaundice underwent a 50-g oral glucose tolerance test (G.T.T.).
• An insulin stimulation test involving oral glucose, intravenous tolbutamide, and glucagon was performed.
• Glucose and insulin levels were measured and compared between patient groups.

Main Results:

• Abnormal glucose responses were observed in 7/12 patients with pancreatic cancer and 6/11 with other obstructive jaundice causes.
• Both groups exhibited low and delayed insulin responses, but insulin levels were significantly lower in pancreatic cancer patients.
• Post-insulin stimulation, non-pancreatic cancer obstructive jaundice patients showed a greater and significantly different insulin response than pancreatic cancer patients, though overlap existed.

Conclusions:

• While glucose metabolism is impaired in obstructive jaundice regardless of cause, significantly lower insulin responses during stimulation tests may indicate pancreatic cancer.
• The insulin stimulation test shows potential in differentiating pancreatic cancer in obstructive jaundice, but individual patient results can overlap.